Nordic Nanovector ASA is a biotechnology company with its head office in Oslo. The company focuses on the development of innovative treatments for cancer, with particular emphasis on targeted therapy. Nordic Nanovector works to develop products that can improve the treatment results for patients with haematological cancers.
The company's research and development is based on advanced technology and scientific insight, and they aim to bring new medicines from the laboratory to clinical use. Nordic Nanovector collaborates with various research institutions and health organizations to promote its development portfolio and contribute to future advances in cancer treatment.
